Showing results (161-170 of 357) with videos related to
Sort By:
Pageof 36
Pediatric Blood & Cancer|March 27, 2014
Early therapy-related myeloid sarcoma and deletion of 9q22.32 to q31.1Molly M Brickler, Donald G Basel, Gabriela Gheorghe, et al.Statistics in Medicine|June 21, 2013
Change-point models to estimate the limit of detectionRyan C May, Haitao Chu, Joseph G Ibrahim, et al.ACS Medicinal Chemistry Letters|May 18, 2019
Second-Generation Tryptamine Derivatives Potently Sensitize Colistin Resistant Bacteria to ColistinBradley M Minrovic, Veronica B Hubble, William T Barker, et al.Medchemcomm|February 16, 2016
Potentiation of <i>Francisella</i> Resistance to Conventional Antibiotics through Small Molecule AdjuvantsMatthew D Stephens, Veroncia B Hubble, Robert K Ernst, et al.Molecular Biosystems|May 22, 2008
Control of bacterial biofilms with marine alkaloid derivativesRobert W Huigens, Luyan Ma, Christopher Gambino, et al.AIDS Research and Human Retroviruses|August 30, 2008
CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathwayMaryanne T Vahey, Zhining Wang, Zhaohui Su, et al.Journal of Virology|February 20, 2024
A novel high-throughput microwell outgrowth assay for HIV-infected cellsAnthony D Fenton, Nancie Archin, Anne-Marie Turner, et al.Plos Pathogens|April 8, 2025
A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latencyManickam Ashokkumar, Terry L Hafer, Abby Felton, et al.The Journal of Infectious Diseases|January 16, 2015
Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoirJulia A Sung, Sharon Lam, Carolina Garrido, et al.Journal of Virology|March 30, 2018
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal <i>Ex Vivo</i>Carolina Garrido, Maria Abad-Fernandez, Marina Tuyishime, et al.Pageof 36